Assessment of Balance and Function After Lateral Ankle Ligament Repair

March 4, 2021 updated by: İnci Hazal Ayas, Gazi University

Approximately 85% of ankle injuries are lateral region injuries.Surgical repair of lateral ligaments is indicated if there is more than 20 degrees of varus or more than 15 mm translation, if conservative treatment is ineffective and degree of damage is high and chronic instability has developed.After the surgery in addition to pain and edema control, weight transfer is not performed on the ankle for 6 weeks.Therefore, this process may adversely affect the muscle strength and range of motion of the ankle, and lower extremity performance and muscular synergies of balance.Although pathological changes caused by ligament damage have been investigated very well in the literature, it is not clear how surgical repair affects these changes. In our study we aim to investigate post-surgical changes.

Primary aim of the study is to evaluate the balance parameters of individuals who have undergone anterior talofibular ligament and / or calcaneofibular ligament repair, and its secondary purpose is to evaluate lower extremity performance, ankle functionality, pain, range of motion and muscle strength and compare them with healthy individuals.

Our hypothesis is that the balance, lower extremity performance and functionality, pain, range of motion and muscle strength of patients who have undergone ankle lateral ligament repair are worse than healthy individuals.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Ankara, Turkey, 06560
        • Recruiting
        • Inci Ayas
        • Contact:
        • Contact:
        • Sub-Investigator:
          • beyza yazgan dağlı

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have undergone ATFL repair surgery at Gazi University Hospital The healthy control group will consist of patient relatives or volunteers to participate in the study.

Description

Inclusion Criteria:

  • Patients who have passed at least 1 year after the operation Unilateral arthroscopic ATFL repair Volunteer to participate in the study

Exclusion Criteria:

  • Any orthopedic conditions, neuromuscular disease, balance disorder, cognitive disorder, history of fracture and surgical operation of the lower extremity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with ATFL repair by arthroscopic method
Patients who have passed at least 1 year after the operation Unilateral arthroscopic ATFL repair Between the ages of 18-65 Volunteer to participate in the study Without any orthopedic conditions, neuromuscular disease, balance disorder, cognitive disorder No history of fracture and surgical operation of the lower extremity

Static balances will be measured with the Biodex-BioSway 950-462 static balance device according to 3 different standard test procedures (Postural Stability Test, Stability Limit Test and Modified Sensori Organization Test) in single foot stance and double foot stance.

Dynamic balances will be evaluated with the Y balance test.

Other Names:
  • Clinical assessment
Functionality will be evaluated with the Lower Extremity Functional Scale and AOFAS (American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale)
Other Names:
  • Clinical assessment
Performance evaluation will be made with a single leg jump test and time up and go test.
Other Names:
  • Clinical assessment
Range of motion (ROM) of the ankle will be measured with an electrogonyometer in dorsi-plantar flexion.
Other Names:
  • Clinical assessment
Control group
Between the ages of 18-65 Volunteer to participate in the study Healthy individuals with no disease

Static balances will be measured with the Biodex-BioSway 950-462 static balance device according to 3 different standard test procedures (Postural Stability Test, Stability Limit Test and Modified Sensori Organization Test) in single foot stance and double foot stance.

Dynamic balances will be evaluated with the Y balance test.

Other Names:
  • Clinical assessment
Functionality will be evaluated with the Lower Extremity Functional Scale and AOFAS (American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale)
Other Names:
  • Clinical assessment
Performance evaluation will be made with a single leg jump test and time up and go test.
Other Names:
  • Clinical assessment
Range of motion (ROM) of the ankle will be measured with an electrogonyometer in dorsi-plantar flexion.
Other Names:
  • Clinical assessment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static balance assessment-Postural Stability Test
Time Frame: 1 year postoperatively
Postural Stability will be measured with the Biodex-BioSway 950-462 static balance device in single foot stance and double foot stance.
1 year postoperatively
Static balance assessment-Stability Limit Test
Time Frame: 1 year postoperatively
Stability Limit will be measured with the Biodex-BioSway 950-462 static balance device in double foot stance.
1 year postoperatively
Static balance assessment-Modified Sensori Organization Test
Time Frame: 1 year postoperatively
Modified Sensori Organization will be measured with the Biodex-BioSway 950-462 static balance device in double foot stance.
1 year postoperatively
Dynamic balance assessment
Time Frame: 1 year postoperatively
Dynamic balances will be evaluated with the Y balance test.
1 year postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jumping performance assessment
Time Frame: 1 year postoperatively
Performance evaluation will be made with a single leg jump test.
1 year postoperatively
Walking ability
Time Frame: 1 year postoperatively
Performance evaluation will be made with time up and go test.
1 year postoperatively
Lower limb functionality assessment
Time Frame: 1 year postoperatively
Functionality will be evaluated with the Lower Extremity Functional Scale.
1 year postoperatively
Foot and ankle functionality assessment
Time Frame: 1 year postoperatively
Functionality will be evaluated with the AOFAS (American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale)
1 year postoperatively
ROM assessment
Time Frame: 1 year postoperatively
Range of motion (ROM) of the ankle will be measured with an electrogonyometer in dorsi-plantar flexion.
1 year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: seyit çıtaker, Gazi University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2021

Primary Completion (Anticipated)

February 1, 2022

Study Completion (Anticipated)

February 1, 2022

Study Registration Dates

First Submitted

February 27, 2021

First Submitted That Met QC Criteria

March 4, 2021

First Posted (Actual)

March 9, 2021

Study Record Updates

Last Update Posted (Actual)

March 9, 2021

Last Update Submitted That Met QC Criteria

March 4, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Functional Performance

Clinical Trials on Balance assessment

3
Subscribe